PL3554501T3 - Deksmedetomidyna lub medetomidyna do zastosowania w leczeniu lęku separacyjnego u zwierząt towarzyszących - Google Patents
Deksmedetomidyna lub medetomidyna do zastosowania w leczeniu lęku separacyjnego u zwierząt towarzyszącychInfo
- Publication number
- PL3554501T3 PL3554501T3 PL17828942T PL17828942T PL3554501T3 PL 3554501 T3 PL3554501 T3 PL 3554501T3 PL 17828942 T PL17828942 T PL 17828942T PL 17828942 T PL17828942 T PL 17828942T PL 3554501 T3 PL3554501 T3 PL 3554501T3
- Authority
- PL
- Poland
- Prior art keywords
- medetomidine
- dexmedetomidine
- companion animals
- separation anxiety
- treating separation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20165960 | 2016-12-13 | ||
| PCT/FI2017/050880 WO2018109272A1 (en) | 2016-12-13 | 2017-12-12 | Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs |
| EP17828942.7A EP3554501B1 (en) | 2016-12-13 | 2017-12-12 | Dexmedetomidine or medetomidine for use in treating separation anxiety in companion animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3554501T3 true PL3554501T3 (pl) | 2021-12-06 |
Family
ID=60957335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17828942T PL3554501T3 (pl) | 2016-12-13 | 2017-12-12 | Deksmedetomidyna lub medetomidyna do zastosowania w leczeniu lęku separacyjnego u zwierząt towarzyszących |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20200069650A1 (pl) |
| EP (1) | EP3554501B1 (pl) |
| JP (1) | JP7065871B2 (pl) |
| KR (1) | KR20190096376A (pl) |
| CN (1) | CN110072524A (pl) |
| AU (1) | AU2017378203B2 (pl) |
| CA (1) | CA3046286A1 (pl) |
| DK (1) | DK3554501T3 (pl) |
| ES (1) | ES2879298T3 (pl) |
| HR (1) | HRP20211310T1 (pl) |
| HU (1) | HUE055565T2 (pl) |
| LT (1) | LT3554501T (pl) |
| MX (1) | MX2019006773A (pl) |
| PL (1) | PL3554501T3 (pl) |
| PT (1) | PT3554501T (pl) |
| RU (1) | RU2759726C2 (pl) |
| SI (1) | SI3554501T1 (pl) |
| WO (1) | WO2018109272A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110337290A (zh) | 2016-12-31 | 2019-10-15 | 比奥克斯塞尔医疗股份有限公司 | 舌下右旋美托咪啶用于治疗激越的用途 |
| AU2019295699A1 (en) | 2018-06-27 | 2021-01-28 | Arx, Llc | Film formulations containing dexmedetomidine and methods of producing them |
| JP2022540706A (ja) | 2019-07-19 | 2022-09-16 | バイオエクセル セラピューティクス，インコーポレイテッド | 鎮静作用のないデクスメデトミジン治療レジメン |
| WO2022195173A1 (en) | 2021-03-19 | 2022-09-22 | Orion Corporation | Tasipimidine formulations and use thereof |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI864570A0 (fi) * | 1986-11-11 | 1986-11-11 | Farmos Oy | Terapeutiskt anvaendbar foerening. |
| JP4438256B2 (ja) * | 2001-06-29 | 2010-03-24 | 味の素株式会社 | 動伴侶動物における問題行動を防止するための医薬組成物および方法 |
| AU2010248776B2 (en) * | 2009-05-15 | 2013-06-06 | Baudax Bio, Inc. | Sublingual dexmedetomidine compositions and methods of use thereof |
| DK2906213T3 (en) * | 2012-10-15 | 2018-02-19 | Orion Corp | VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY |
-
2017
- 2017-12-12 SI SI201730829T patent/SI3554501T1/sl unknown
- 2017-12-12 RU RU2019121690A patent/RU2759726C2/ru active
- 2017-12-12 CA CA3046286A patent/CA3046286A1/en active Pending
- 2017-12-12 WO PCT/FI2017/050880 patent/WO2018109272A1/en unknown
- 2017-12-12 EP EP17828942.7A patent/EP3554501B1/en active Active
- 2017-12-12 US US16/468,707 patent/US20200069650A1/en active Pending
- 2017-12-12 PT PT178289427T patent/PT3554501T/pt unknown
- 2017-12-12 JP JP2019551751A patent/JP7065871B2/ja active Active
- 2017-12-12 ES ES17828942T patent/ES2879298T3/es active Active
- 2017-12-12 PL PL17828942T patent/PL3554501T3/pl unknown
- 2017-12-12 DK DK17828942.7T patent/DK3554501T3/da active
- 2017-12-12 MX MX2019006773A patent/MX2019006773A/es unknown
- 2017-12-12 KR KR1020197020353A patent/KR20190096376A/ko not_active IP Right Cessation
- 2017-12-12 AU AU2017378203A patent/AU2017378203B2/en active Active
- 2017-12-12 CN CN201780076704.9A patent/CN110072524A/zh active Pending
- 2017-12-12 LT LTEPPCT/FI2017/050880T patent/LT3554501T/lt unknown
- 2017-12-12 HU HUE17828942A patent/HUE055565T2/hu unknown
-
2021
- 2021-08-13 HR HRP20211310TT patent/HRP20211310T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190096376A (ko) | 2019-08-19 |
| LT3554501T (lt) | 2021-07-12 |
| HUE055565T2 (hu) | 2021-11-29 |
| EP3554501B1 (en) | 2021-06-09 |
| EP3554501A1 (en) | 2019-10-23 |
| DK3554501T3 (da) | 2021-07-19 |
| RU2019121690A (ru) | 2021-01-15 |
| HRP20211310T1 (hr) | 2021-11-26 |
| CN110072524A (zh) | 2019-07-30 |
| AU2017378203B2 (en) | 2022-12-08 |
| SI3554501T1 (sl) | 2021-09-30 |
| AU2017378203A1 (en) | 2019-07-25 |
| WO2018109272A1 (en) | 2018-06-21 |
| JP2020500944A (ja) | 2020-01-16 |
| US20200069650A1 (en) | 2020-03-05 |
| MX2019006773A (es) | 2019-08-22 |
| ES2879298T3 (es) | 2021-11-22 |
| RU2019121690A3 (pl) | 2021-04-07 |
| PT3554501T (pt) | 2021-07-05 |
| CA3046286A1 (en) | 2018-06-21 |
| RU2759726C2 (ru) | 2021-11-17 |
| JP7065871B2 (ja) | 2022-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3556775T1 (sl) | Protitelesa proti-LAG-3 za zdravljenje hematoloških malignosti | |
| AU362358S (en) | Pet treat | |
| PL3554501T3 (pl) | Deksmedetomidyna lub medetomidyna do zastosowania w leczeniu lęku separacyjnego u zwierząt towarzyszących | |
| HK1245641A1 (zh) | 次氯酸製劑及治療皮膚病的方法 | |
| EP3119188C0 (en) | SYSTEM AND METHOD FOR TREATING FARM ANIMALS | |
| HK1245804A1 (zh) | 用於治療pvns的抗csf1r抗體 | |
| IL250724A0 (en) | Methods for treating multiple myeloma with immunomodulatory compounds in combination with antibodies | |
| IL248767B (en) | Trimethoxyphenyl-benzaimidazole compounds for cancer treatment | |
| SG11201700663WA (en) | Regulating method and regulating device for water treatment | |
| HK1257024A1 (zh) | 用於治療伴侣動物的aav-epo | |
| IL252904A0 (en) | Methods and factors for treating diseases | |
| GB201403969D0 (en) | Compounds for use in controlling body fat | |
| EP3242557A4 (en) | Methods of treating diarrhea in companion animals | |
| GB201419207D0 (en) | Animal halter | |
| GB201414192D0 (en) | Apparatus for treating animals | |
| PL3209120T3 (pl) | Uprząż dla psa | |
| PL3030208T3 (pl) | Urządzenie do leczenia układu moczowo-płciowego kobiet | |
| GB201612052D0 (en) | Animal claw shearing apparatuses and methods of using the same | |
| GB201400311D0 (en) | Treating Susceptibility | |
| GB201607454D0 (en) | Improvements in or relating to saddlery | |
| GB201615315D0 (en) | Improvements in or relating to animal handling apparatus | |
| PL3151863T3 (pl) | Wodno alkoholowy system do leczenia paznokci | |
| GB201421889D0 (en) | Improvements in or relating to effluent treatment | |
| PT3862003T (pt) | Inibidor de sglt-2 para utilização no tratamento de um distúrbio metabólico em animais felinos | |
| GB201416343D0 (en) | Improvements in or relating to rope guards |